Central serous chorioretinopathy, corticosteroids, and uveitis

Ocular Immunology and Inflammation

Volumn 20, Issue 2, 2012, Pages 76-85

  Khairallah, Moncef ^a   Kahloun, Rim ^a   Tugal Tutkun, Ilknur ^b  

^a FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Central serous chorioretinopathy; Corticosteroids; Retinal pigment epithelium detachment; Serous retinal detachment; Uveitis

Indexed keywords

CYCLOSPORIN; METHYLPREDNISOLONE; PREDNISONE; TRIAMCINOLONE ACETONIDE;

ADULT; ARTICLE; BEHCET DISEASE; BEHCET UVEITIS; CATECHOLAMINE RELEASE; CENTRAL SEROUS RETINOPATHY; CHOROID DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE EXACERBATION; FEMALE; HLA B27 ASSOCIATED UVEITIS; HUMAN; MALE; OPTICAL COHERENCE TOMOGRAPHY; PATHOPHYSIOLOGY; PIGMENT EPITHELIUM; PREVALENCE; PROGNOSIS; RETINA DETACHMENT; RETINA DISEASE; RETINA FLUORESCEIN ANGIOGRAPHY; SUBRETINAL FLUID; SYSTEMIC LUPUS ERYTHEMATOSUS; TOXOPLASMOSIS; TREATMENT DURATION; UVEITIS; VISUAL ACUITY; VISUAL IMPAIRMENT; VITILIGINOUS CHORIORETINITIS; VOGT KOYANAGI SYNDROME;

ADRENAL CORTEX HORMONES; CENTRAL SEROUS CHORIORETINOPATHY; DIAGNOSTIC ERRORS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; RETINAL DETACHMENT; TREATMENT OUTCOME; UVEITIS; VISUAL ACUITY;

EID: 84858212489     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.3109/09273948.2011.650776     Document Type: Article

References (69)

1. Ross A, Ross AH, Mohamed Q. Review and update of central serous chorioretinopathy. Curr Opin Ophthalmol. 2011;22:166-173.
2. wang M, Munch IC, Hasler Pw, et al. Central serous chori-oretinopathy. Acta Ophthalmol. 2008;86:126-145.
3. Marcuson J, Riley T. Central serous chorioretinopathy. Optometry. 2008;79:241-251.
4. Haimovici R, Koh S, Gagnon DR, et al. Central Serous Chorioretinopathy Case-Control Study group. Risk factors for central serous chorioretinopathy: a case-control study. Ophthalmology. 2004;111:244-249. (Pubitemid 38183222)
5. Bouzas EA, Karadimas P, Pournaras CJ. Central serous chorioretinopathy and glucocorticoids. Surv Ophthalmol. 2002;47:431-448. (Pubitemid 35341618)
6. Carvalho-Recchia CA, Yannuzzi LA, Negrão S, et al. Corticosteroids and central serous chorioretinopathy. Ophthalmology. 2002;109:1834-1837.
7. Jampol LM, Weinreb R, Yannuzzi L. involvement of corti-costeroids and catecholamines in the pathogenesis of central serous chorioretinopathy: a rationale for new treatment strategies. Ophthalmology. 2002;109:1765-1766.
8. Karadimas P, Bouzas EA. glucocorticoid use represents a risk factor for central serous chorioretinopathy: a prospective, case-control study. Graefes Arch Clin Exp Ophthalmol. 2004;242:800-802. (Pubitemid 39386382)
9. Haimovici R, Rumelt S, Melby J. Endocrine abnormalities in patients with central serous chorioretinopathy. Ophthalmology. 2003;110:698-703. (Pubitemid 36520065)
10. Jampol LM, Weinreb R, Yannuzzi L. Involvement of corti-costeroids and catecholamines in the pathogenesis of central serous chorioretinopathy: a rationale for new treatment strategies. Ophthalmology. 2002;109:1765-1766.
11. Arndt C, Sari A, Ferre M, et al. Electrophysiological effects of corticosteroids on the retinal pigment epithelium. Invest Ophthalmol Vis Sci. 2001;42:472-475. (Pubitemid 32121482)
12. Sibayan SA, Kobuch K, Spiegel D, et al. Epinephrine, but not dexamethasone, induces apoptosis in retinal pigment epithelial cells in vitro: possible implications on the pathogenesis of central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol. 2000;238:515-519. (Pubitemid 30420872)
13. Yamada R, Yamada S, Ishii A, et al. Evaluation of tissue plasminogen activator and plasminogen activator inhib-itor-1 in blood obtained from patients of idiopathic central serous chorioretinopathy. Nippon Ganka Gakkai Zasshi. 1993;97:955-960. (Pubitemid 23280935)
14. Caccavale A, Romanazzi F, Imparato M, et al. Central serous chorioretinopathy: a pathogenetic model. Clin Ophthalmol. 2011;5:239-243.
15. Karadimas P, Kapetanios A, Bouzas EA. Central serous cho-rioretinopathy after local application of glucocorticoids for skin disorders. Arch Ophthalmol. 2004;122:784-786. (Pubitemid 38596264)
16. Fernandez CF, Mendoza AJ, Arevalo JF. Central serous chori-oretinopathy associated with topical dermal corticosteroids. Retina. 2004;24:471-474. (Pubitemid 38780486)
17. Mondal LK, Sarkar K, Datta H, et al. Acute bilateral central serous chorioretinopathy following intra-articular injection of corticosteroid. Indian J Ophthalmol. 2005;53:132-134.
18. Iida T, Spaide RF, Negrao SG, et al. Central serous chori-oretinopathy after epidural corticosteroid injection. Am J Ophthalmol. 2001;132:423-425. (Pubitemid 32768623)
19. Haimovici R, Gragoudas ES, Duker DS, et al. Central serous chorioretinopathy associated with inhaled or intranasal cor-ticosteroids. Ophthalmology. 1997;104:1653-1660. (Pubitemid 28053467)
20. Fardin B, Weissgold DJ. Central serous chorioretinopathy after inhaled steroid use for post-mycoplasmal bronchos-pasm. Br J Ophthalmol. 2002;86:1065-1066. (Pubitemid 34953628)
21. Shah VA, Randhawa S, Boldt HC, et al. Central serous chorioretinopathy in giant cell arteritis. Semin Ophthalmol. 2006;21:45-48. (Pubitemid 43879515)
22. Bevis T, Ratnakaram R, Smith MF, et al. Visual loss due to central serous chorioretinopathy during corticosteroid treatment for giant cell arteritis. Clin Exp Ophthalmol. 2005;33:437-439. (Pubitemid 44144622)
23. Bouyon A, Costedoat-Chalumeau N, Limal N, et al. Central serous chorioretinopathy and systemic diseases report of 2 cases associated with corticotherapy. Rev Med Interne. 2006;27:487-491. (Pubitemid 43815590)
24. Edalati K, Roesch MT, Buchanan ML, et al. Central serous chorioretinopathy and idiopathic nonhistaminergic angioe-dema. Can J Ophthalmol. 2009;44:606-607.
25. Otsuka S, Ohba N, Nakao K. A long-term follow-up study of severe variant of central serous chorioretinopathy. Retina. 2002;22:25-32. (Pubitemid 41070747)
26. Bowie EM, Folk JC, Barnes CH. Corticosteroids, central serous chorioretinopathy, and neurocysticercosis. Arch Ophthalmol. 2004;122:281-283. (Pubitemid 38176499)
27. Kunavisarut P, Pathanapitoon K, Van Schooneveld M, et al. Chronic central serous chorioretinopathy associated with serous retinal detachment in a series of Asian patients. Ocul Immunol Infamm. 2009;17:269-277.
28. Kang JE, Kim HJ, Boo HD, et al. Surgical management of bilateral exudative retinal detachment associated with central serous chorioretinopathy. Korean J Ophthalmol. 2006;20:131-138.
29. Yang CM, Lin CP. Bullous retinal detachment in a patient with central serous chorioretinopathy. J Formos Med Assoc. 1998;97:711-714.
30. Fujimoto H, Gomi F, wakabayashi T, et al. Morphologic changes in acute central serous chorioretinopathy evaluated by Fourier-domain optical coherence tomography. Ophthalmology. 2008;115:1494-1500,500.e1-2.
31. Yamaguchi Y, Otani T, Kishi S. Tomographic features of serous retinal detachment with multilobular dye pooling in acute Vogt-Koyanagi-Harada disease. Am J Ophthalmol. 2007;144:260-265. (Pubitemid 47094726)
32. Menchini U, Virgili G, Lanzetta P, et al. Indocyanine green angiography in central serous chorioretinopathy: ICg angiog-raphy in CSC. Int Ophthalmol. 1997;21:57-69. (Pubitemid 27512511)
33. Herbort CP, Mantovani A, Bouchenaki N. Indocyanine green angiography in Vogt-Koyanagi-Harada disease: angio-graphic signs and utility in patient follow-up. Int Ophthalmol. 2007;27:173-182. (Pubitemid 46909258)
34. Koizumi H, Maruyama K, Kinoshita S. Blue light and near-infrared fundus autofuorescence in acute Vogt-Koyanagi-Harada disease. Br J Ophthalmol. 2010;94:1499-1505.
35. Dinc UA, Tatlipinar S, Yenerel M, et al. Fundus autofuores-cence in acute and chronic central serous chorioretinopathy. Clin Exp Optom. 2011;94:452-457.
36. Roisman L, Lavinsky D, Magalhaes F, et al. Fundus autofuo-rescence and spectral domain OCT in central serous chori-oretinopathy. J Ophthalmol. 2011;2011:706-849.
37. Gass JD, Little H. bilateral bullous exudative retinal detachment complicating idiopathic central serous chorioretinopa-thy during systemic corticosteroid therapy. Ophthalmology. 1995;102:737-747.
38. Arantes TE, Garcia CR, Rossi MR, et al. Spectral domain optical coherence tomography and angiographic fnd-ings in central serous chorioretinopathy complicated by bilateral nonrhegmatogenous retinal detachment associated with systemic corticosteroids. Ocul Immunol Infamm. 2009;17:316-318.
39. Ishida Y, Kato T, Minamoto A, et al. Retinal pigment epithelial tear in a patient with central serous chorioretinopathy treated with corticosteroids. Retina. 2004;24:633-636. (Pubitemid 39079900)
40. gómez-Valcárcel M, Sinisterra-Pava JP, Arellanes- garcía L. Central serous chorioretinopathy versus sympathetic ophthalmia: case report. Arch Soc Esp Oftalmol. 2004;79: 507-510.
41. Cunningham ET Jr, Alfred PR, Irvine AR. Central serous cho-rioretinopathy in patients with systemic lupus erythemato-sus. Ophthalmology. 1996;103:2081-2090. (Pubitemid 27024629)
42. Bouzas E, Mastorakos G. Central serous retinopathy in systemic lupus erythematosus: a manifestation of the disease or of its treatment? Br J Ophthalmol. 1994;78:420-421. (Pubitemid 24168006)
43. Khng CG, Yap EY, Au-Eong KG, et al. Central serous retin-opathy complicating systemic lupus erythematosus: a case series. Clin Exp Ophthalmol. 2000;28:309-313.
44. Salchow DJ, Weiss MJ. Retinal pigment epithelial detachment in sarcoidosis. Ocul Immunol Infamm. 2006;14:245-248. (Pubitemid 44266804)
45. Sheth Hg, Laverde-Konig T, Raina J. TINU-associated retinal pigment epithelium detachments: a possible novel posterior segment feature. Int Ophthalmol. 2009;29:179-181.
46. Hannouche D, Korobelnik JF, Cochereau I, et al. Systemic lupus erythematosus with choroidopathy and serous retinal detachment. Int Ophthalmol. 1995;19:125-127.
47. Laviña AM, Agarwal A, Hunyor A, et al. Lupus choroidopa-thy and choroidal effusions. Retina. 2002;22:643-647.
48. Gharbiya M, Bozzoni-Pantaleoni F, Augello F, et al. Indocyanine green angiographic fndings in systemic lupus erythematosus choroidopathy. Am J Ophthalmol. 2002; 134:286-290. (Pubitemid 34831844)
49. gharbiya M, Pecci g, Baglio V, et al. Indocyanine green angiographic fndings for patients with systemic lupus ery-thematosus nephropathy. Retina. 2006;26:159-164. (Pubitemid 44400710)
50. Gupta SR, Suhler EB, Rosenbaum JT. The dilemma of central serous retinopathy, a corticosteroid-induced complication, in patients with ocular infammatory disease. J Rheumatol. 2010;37:1973-1974.
51. Schalenbourg A, Leys A, De Courten C, et al. Corticosteroid-induced central serous chorioretinopathy in patients with ocular infammatory disorders. Klin Monbl Augenheilkd. 2002;219:264-267. (Pubitemid 34625232)
52. Baumal CR, Martidis A, Truong SN. Central serous chori-oretinopathy associated with periocular corticosteroid injection treatment for HLA-B27-associated iritis. Arch Ophthalmol. 2004;122:926-928. (Pubitemid 38736258)
53. Chaine G, Haouat M, Menard-Molcard C, et al. Central serous chorioretinopathy and systemic steroid therapy. J Fr Ophtalmol. 2001;24:139-146. (Pubitemid 32218722)
54. Imasawa M, Ohshiro T, gotoh T, et al. Central serous cho-rioretinopathy following vitrectomy with intravitreal tri-amcinolone acetonide for diabetic macular oedema. Acta Ophthalmol Scand. 2005;83:132-133.
55. Bouzas EA, Moret P, Pournaras CJ. Central serous cho-rioretinopathy complicating solar retinopathy treated with glucocorticoids. Graefes Arch Clin Exp Ophthalmol. 1999;237:166-168. (Pubitemid 29137306)
56. Wakakura M, Song E, Ishikawa S. Corticosteroid-induced central serous chorioretinopathy. Jpn J Ophthalmol. 1997;41:180-185.
57. Fawzi AA, Holland GN, Kreiger AE, et al. Central serous chorioretinopathy after solid organ transplantation. Ophthalmology. 2006;113:805-813.e5.
58. Gass JD, Little H. Bilateral bullous exudative retinal detachment complicating idiopathic central serous chorioretinopa-thy during systemic corticosteroid therapy. Ophthalmology. 1995;102:737-747.
59. Hooymans JM. Fibrotic scar formation in central serous chorioretinopathy developed during systemic treatment with corticosteroids. Graefes Arch Clin Exp Ophthalmol. 1998;236:876-879. (Pubitemid 28491199)
60. Loo JL, Lee SY, Ang CL. Long-term corticosteroids lead to blindness? A case series of central serous chorioretinopa-thy induced by corticosteroids. Ann Acad Med Singapore. 2006;35:496-499.
61. Fawzi AA, Holland GN, Kreiger AE, et al. Central serous chorioretinopathy after solid organ transplantation. Ophthalmology. 2006;113:805-13.e5.
62. Schatz H, McDonald HR, Johnson RN, et al. Subretinal fbrosis in central serous chorioretinopathy. Ophthalmology. 1995;102:1077-1088.
63. Sharma T, Badrinath SS, Gopal L, et al. Subretinal fbrosis and nonrhegmatogenous retinal detachment associated with multifocal central serous chorioretinopathy. Retina. 1998;18:23-29. (Pubitemid 28128401)
64. Sharma T, Shah N, Rao M, et al. Visual outcome after discontinuation of corticosteroids in atypical severe central serous chorioretinopathy. Ophthalmology. 2004;111:1708-1714. (Pubitemid 39179687)
65. Iida T, Spaide RF, Haas A, et al. Leopard-spot pattern of yellowish subretinal deposits in central serous chorioretinopa-thy. Arch Ophthalmol. 2002;120:37-42. (Pubitemid 34721359)
66. Mendrinos E, Mavrakanas N, Dang-Burgener NP, et al. Bilateral multifocal retinal pigment epithelium detachments associated with systemic corticosteroids. Eur J Ophthalmol. 2008;18:649-651.
67. Harikrishnan A, Anderson K, Patra S. Severe visual loss secondary to central serous chorioretinopathy following prolonged immue suppression with oral prednisolone. JRSM Short Rep. 2010;1:31.
68. Lim Jw, Kim MU. The effcacy of intravitreal bevacizumab for idiopathic central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol. 2011;249:969-974.
69. Wakakura M, Ishikawa S. Central serous chorioretinopa-thy complicating systemic corticosteroid treatment. Br J Ophthalmol. 1984;68:329-331. (Pubitemid 15118321)